vs

Side-by-side financial comparison of HERITAGE FINANCIAL CORP (HFWA) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Schrodinger, Inc. is the larger business by last-quarter revenue ($87.2M vs $66.3M, roughly 1.3× HERITAGE FINANCIAL CORP). Schrodinger, Inc. runs the higher net margin — 37.3% vs 33.5%, a 3.8% gap on every dollar of revenue. On growth, HERITAGE FINANCIAL CORP posted the faster year-over-year revenue change (16.3% vs -1.2%). HERITAGE FINANCIAL CORP produced more free cash flow last quarter ($85.7M vs $-16.1M). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 16.8%).

Heritage Financial Corp (WA) is a U.S. regional financial holding company headquartered in Washington state. It provides comprehensive commercial and consumer banking services, including deposit products, small business loans, residential mortgages, personal lending and wealth management solutions, primarily serving local communities across the Pacific Northwest, with core customer segments covering small-to-medium enterprises and retail clients.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

HFWA vs SDGR — Head-to-Head

Bigger by revenue
SDGR
SDGR
1.3× larger
SDGR
$87.2M
$66.3M
HFWA
Growing faster (revenue YoY)
HFWA
HFWA
+17.5% gap
HFWA
16.3%
-1.2%
SDGR
Higher net margin
SDGR
SDGR
3.8% more per $
SDGR
37.3%
33.5%
HFWA
More free cash flow
HFWA
HFWA
$101.8M more FCF
HFWA
$85.7M
$-16.1M
SDGR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
16.8%
HFWA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HFWA
HFWA
SDGR
SDGR
Revenue
$66.3M
$87.2M
Net Profit
$22.2M
$32.5M
Gross Margin
65.7%
Operating Margin
38.7%
-19.7%
Net Margin
33.5%
37.3%
Revenue YoY
16.3%
-1.2%
Net Profit YoY
86.4%
180.8%
EPS (diluted)
$0.65
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HFWA
HFWA
SDGR
SDGR
Q4 25
$66.3M
$87.2M
Q3 25
$65.7M
$54.3M
Q2 25
$56.5M
$54.8M
Q1 25
$57.6M
$59.6M
Q4 24
$57.1M
$88.3M
Q3 24
$54.8M
$35.3M
Q2 24
$56.4M
$47.3M
Q1 24
$48.6M
$36.6M
Net Profit
HFWA
HFWA
SDGR
SDGR
Q4 25
$22.2M
$32.5M
Q3 25
$19.2M
$-32.8M
Q2 25
$12.2M
$-43.2M
Q1 25
$13.9M
$-59.8M
Q4 24
$11.9M
$-40.2M
Q3 24
$11.4M
$-38.1M
Q2 24
$14.2M
$-54.0M
Q1 24
$5.7M
$-54.7M
Gross Margin
HFWA
HFWA
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
HFWA
HFWA
SDGR
SDGR
Q4 25
38.7%
-19.7%
Q3 25
34.0%
-84.6%
Q2 25
25.6%
-96.6%
Q1 25
28.1%
-85.5%
Q4 24
28.6%
-23.5%
Q3 24
23.8%
-193.9%
Q2 24
28.4%
-111.4%
Q1 24
14.1%
-184.3%
Net Margin
HFWA
HFWA
SDGR
SDGR
Q4 25
33.5%
37.3%
Q3 25
29.2%
-60.4%
Q2 25
21.6%
-78.8%
Q1 25
24.2%
-100.4%
Q4 24
20.9%
-45.5%
Q3 24
20.8%
-108.1%
Q2 24
25.1%
-114.2%
Q1 24
11.8%
-149.5%
EPS (diluted)
HFWA
HFWA
SDGR
SDGR
Q4 25
$0.65
$0.45
Q3 25
$0.55
$-0.45
Q2 25
$0.36
$-0.59
Q1 25
$0.40
$-0.82
Q4 24
$0.34
$-0.55
Q3 24
$0.33
$-0.52
Q2 24
$0.41
$-0.74
Q1 24
$0.16
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HFWA
HFWA
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$233.1M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$921.5M
$364.1M
Total Assets
$7.0B
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HFWA
HFWA
SDGR
SDGR
Q4 25
$233.1M
$395.5M
Q3 25
$245.5M
$391.2M
Q2 25
$254.1M
$450.2M
Q1 25
$248.7M
$500.3M
Q4 24
$117.1M
$352.1M
Q3 24
$175.6M
$388.7M
Q2 24
$113.8M
$377.3M
Q1 24
$189.6M
$431.1M
Stockholders' Equity
HFWA
HFWA
SDGR
SDGR
Q4 25
$921.5M
$364.1M
Q3 25
$904.1M
$321.4M
Q2 25
$888.2M
$342.9M
Q1 25
$881.5M
$373.5M
Q4 24
$863.5M
$421.4M
Q3 24
$874.5M
$449.4M
Q2 24
$850.5M
$474.0M
Q1 24
$847.6M
$513.7M
Total Assets
HFWA
HFWA
SDGR
SDGR
Q4 25
$7.0B
$726.2M
Q3 25
$7.0B
$653.7M
Q2 25
$7.1B
$688.2M
Q1 25
$7.1B
$743.0M
Q4 24
$7.1B
$823.2M
Q3 24
$7.2B
$669.3M
Q2 24
$7.1B
$688.4M
Q1 24
$7.1B
$737.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HFWA
HFWA
SDGR
SDGR
Operating Cash FlowLast quarter
$94.8M
$-16.1M
Free Cash FlowOCF − Capex
$85.7M
$-16.1M
FCF MarginFCF / Revenue
129.1%
-18.5%
Capex IntensityCapex / Revenue
13.8%
0.0%
Cash ConversionOCF / Net Profit
4.26×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$149.0M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HFWA
HFWA
SDGR
SDGR
Q4 25
$94.8M
$-16.1M
Q3 25
$25.1M
$-61.9M
Q2 25
$22.5M
$-52.2M
Q1 25
$19.3M
$144.1M
Q4 24
$64.5M
$-31.1M
Q3 24
$24.2M
$-33.3M
Q2 24
$6.8M
$-53.7M
Q1 24
$12.9M
$-39.3M
Free Cash Flow
HFWA
HFWA
SDGR
SDGR
Q4 25
$85.7M
$-16.1M
Q3 25
$24.4M
$-62.4M
Q2 25
$20.9M
$-52.5M
Q1 25
$18.1M
$143.5M
Q4 24
$61.0M
$-32.0M
Q3 24
$23.2M
$-34.6M
Q2 24
$6.0M
$-54.7M
Q1 24
$12.0M
$-43.4M
FCF Margin
HFWA
HFWA
SDGR
SDGR
Q4 25
129.1%
-18.5%
Q3 25
37.1%
-114.8%
Q2 25
37.0%
-95.9%
Q1 25
31.4%
240.9%
Q4 24
107.0%
-36.2%
Q3 24
42.4%
-98.0%
Q2 24
10.6%
-115.6%
Q1 24
24.7%
-118.5%
Capex Intensity
HFWA
HFWA
SDGR
SDGR
Q4 25
13.8%
0.0%
Q3 25
1.0%
0.9%
Q2 25
2.8%
0.6%
Q1 25
2.0%
1.0%
Q4 24
6.1%
1.0%
Q3 24
1.7%
3.8%
Q2 24
1.5%
2.1%
Q1 24
1.8%
11.2%
Cash Conversion
HFWA
HFWA
SDGR
SDGR
Q4 25
4.26×
-0.50×
Q3 25
1.31×
Q2 25
1.84×
Q1 25
1.38×
Q4 24
5.41×
Q3 24
2.12×
Q2 24
0.48×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HFWA
HFWA

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons